South Africa Bacteriophages Therapy Market to 2032
Overview
The South Africa Bacteriophages Therapy Market is expected to reach a 0.59 USD Million by 2032 and is projected to grow at a CAGR of 6.79% from 2025 to 2032.
South Africa Bacteriophages Therapy Market 2018-2032 USD Million
South Africa Bacteriophages Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 0.42 USD Million
- Projected Market Size (2032): 0.59 USD Million
- CAGR (2025-2032): 6.79%
Key Findings of South Africa Bacteriophages Therapy Market
- The South Africa Bacteriophages Therapy Market was valued at 0.42 USD Million in 2024.
- The South Africa Bacteriophages Therapy Market is likely to grow at a CAGR of 6.79% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 0.38 USD Million
- The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 7.47% during the forecast period from 2024 to 2032.
South Africa Bacteriophages Therapy Market Scope
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
- Third Party Distributors
- Direct Tender
- Others
- Parenteral
- Dermal
- Oral
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
- Water-Soluble Jelly Base
- Sterile Broth Culture
- Lysogenic
- Lytic
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
South Africa Bacteriophages Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 0.42 USD Million |
| Market Value in 2032 | 0.59 USD Million |
| CAGR (2025-2032) | 6.79% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Route Of Administration,Application,Base,Type,Target |
Regional Insights:
-
Leading Market (2024-2032): South Africa, leading in terms of revenue 0.42 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 0.42 USD Million in 2024.
Segments and Scope
-
South Africa Bacteriophages Therapy Market to 2032, By End User
- Hospitals is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.15 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.42 % in forecast period 2025-2032.
-
South Africa Bacteriophages Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.37 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.87 % in forecast period 2025-2032.
-
South Africa Bacteriophages Therapy Market to 2032, By Route Of Administration
- Oral is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.17 USD Million in the year 2024.
- Dermal is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.36 % in forecast period 2025-2032.
-
South Africa Bacteriophages Therapy Market to 2032, By Application
- Postoperative Wound Infections is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.14 USD Million in the year 2024.
- Supperative Skin Infections is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 7.23 % in forecast period 2025-2032.
-
South Africa Bacteriophages Therapy Market to 2032, By Base
- Sterile Broth Culture is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.29 USD Million in the year 2024.
- Sterile Broth Culture is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 7.01 % in forecast period 2025-2032.
-
South Africa Bacteriophages Therapy Market to 2032, By Type
- Lytic is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.38 USD Million in the year 2024.
- Lytic is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.90 % in forecast period 2025-2032.
-
South Africa Bacteriophages Therapy Market to 2032, By Target
- Staphylococcus is the largest segment in South Africa Bacteriophages Therapy Market to 2032 with a revenue of 0.11 USD Million in the year 2024.
- Escherichia coli is the Fastest growing segment in South Africa Bacteriophages Therapy Market to 2032 with a Growth rate of 6.42 % in forecast period 2025-2032.
South Africa Bacteriophages Therapy Market Company Share Analysis
| Company Name |
|
||
| Microgen | |||
| MICREOS | |||
| Intralytix, Inc. | |||
| LOCUS BIOSCIENCES, INC. | |||
| Phagelux, Inc. | |||
South Africa Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
South Africa Bacteriophages Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
South Africa Bacteriophages Therapy Market Scope
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
- Third Party Distributors
- Direct Tender
- Others
- Parenteral
- Dermal
- Oral
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
- Water-Soluble Jelly Base
- Sterile Broth Culture
- Lysogenic
- Lytic
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Frequently Asked Questions
South Africa Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.